[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR3026758T3 - Lactobacillus strains of human origin, their compositions and uses thereof - Google Patents

Lactobacillus strains of human origin, their compositions and uses thereof

Info

Publication number
GR3026758T3
GR3026758T3 GR980400957T GR980400957T GR3026758T3 GR 3026758 T3 GR3026758 T3 GR 3026758T3 GR 980400957 T GR980400957 T GR 980400957T GR 980400957 T GR980400957 T GR 980400957T GR 3026758 T3 GR3026758 T3 GR 3026758T3
Authority
GR
Greece
Prior art keywords
compositions
lactobacillus strains
human origin
lactobacillus
strains
Prior art date
Application number
GR980400957T
Other languages
English (en)
Inventor
Lorenzo Morelli
Vittorio Bottazzi
Luigia Gozzini
Haen Christoph De
Original Assignee
Bracco Spa
Dibra Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3026758(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ITMI941073A external-priority patent/IT1269838B/it
Priority claimed from ITMI941773A external-priority patent/IT1274733B/it
Application filed by Bracco Spa, Dibra Spa filed Critical Bracco Spa
Publication of GR3026758T3 publication Critical patent/GR3026758T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
GR980400957T 1994-05-26 1998-04-30 Lactobacillus strains of human origin, their compositions and uses thereof GR3026758T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI941073A IT1269838B (it) 1994-05-26 1994-05-26 Ceppi di lattobacilli di origine umana e loro usi
ITMI941773A IT1274733B (it) 1994-08-25 1994-08-25 Ceppo del genere lactobacillus di origine umana e suoi usi
PCT/EP1995/001886 WO1995033046A1 (en) 1994-05-26 1995-05-18 Lactobacillus strains of human origin, their compositions and uses thereof

Publications (1)

Publication Number Publication Date
GR3026758T3 true GR3026758T3 (en) 1998-07-31

Family

ID=26331139

Family Applications (2)

Application Number Title Priority Date Filing Date
GR970300016T GR970300016T1 (en) 1994-05-26 1997-05-30 Lactobacillus strains of human origin, their compositions and uses thereof
GR980400957T GR3026758T3 (en) 1994-05-26 1998-04-30 Lactobacillus strains of human origin, their compositions and uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR970300016T GR970300016T1 (en) 1994-05-26 1997-05-30 Lactobacillus strains of human origin, their compositions and uses thereof

Country Status (18)

Country Link
US (1) US5709857A (el)
EP (1) EP0760848B1 (el)
JP (1) JP3653277B2 (el)
CN (1) CN1094972C (el)
AT (1) ATE163042T1 (el)
AU (1) AU686389B2 (el)
BR (1) BR9507752A (el)
CA (1) CA2191213C (el)
DE (2) DE760848T1 (el)
DK (1) DK0760848T3 (el)
ES (1) ES2099056T3 (el)
FI (1) FI119059B (el)
GR (2) GR970300016T1 (el)
HU (1) HU220190B (el)
MX (1) MX9605807A (el)
NO (1) NO316644B1 (el)
NZ (1) NZ287420A (el)
WO (1) WO1995033046A1 (el)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN175495A0 (en) 1995-03-14 1995-04-13 University Of New England, The Method and composition for the prevention of the over production of acid
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
IT1289159B1 (it) 1997-01-08 1998-09-29 Yurta S R L Composizioni farmaceutiche e alimentari a base di batteri del genere acetobacter
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
US7202219B1 (en) * 1998-02-24 2007-04-10 Md Foods Amba Use of D-tagatose as a prebiotic food component
EP0956858B1 (en) 1998-04-30 2001-10-31 Renata Maria Anna Cavaliere Vesely Pharmaceutical compositions containing Lactobacillus brevis and Lactobacillus salivarius for treatment of vaginal infections
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
HUP0200374A2 (en) * 1999-03-11 2002-06-29 Nestle Sa Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
US20040105848A1 (en) * 1999-04-30 2004-06-03 Natarajan Ranganathan Enteric dialysis compositions and methods
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
US6641808B1 (en) * 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
WO2001058465A2 (en) * 2000-02-10 2001-08-16 Gregor Reid Probiotic therapy for newborns
CA2411944C (en) * 2000-06-09 2010-12-14 Baylor College Of Medicine The combination of antimicrobial agents and bacterial interference to coat medical devices
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
WO2002058712A2 (en) 2000-12-18 2002-08-01 Probio Health Probiotic compounds derived from lactobacillus casei strain ke01
US7214370B2 (en) * 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
NO318426B1 (no) * 2001-10-02 2005-04-18 Neurozym Biotech As Et materiale for a senke konsentrasjonen av patogene tarmpeptider
US8147821B2 (en) 2002-02-21 2012-04-03 Grain Processing Corporation Method for drying biomaterials
ATE409220T1 (de) 2002-03-21 2008-10-15 Bifodan As Lactobacillus-stämme
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
CA2547144C (en) 2005-05-16 2010-02-02 Grain Processing Corporation Method for drying spent filter media
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
DE602007003093D1 (de) * 2007-07-13 2009-12-17 Unilever Nv Nahrungsmittel mit Bakterien und Sorbitan-Fettsäure
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
EP2293802A4 (en) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc LACTOSE COMPOSITIONS HAVING REDUCED LACTOSE CONTENT
KR101003149B1 (ko) * 2008-10-31 2010-12-22 전남대학교산학협력단 병변 치료용 박테리아 기반의 마이크로로봇
EP2206506A1 (en) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
EP2400839B1 (en) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2248908A1 (en) 2009-05-05 2010-11-10 Eurolactis Group S.A. Probiotic microorganisms isolated from donkey milk
WO2011009848A2 (en) 2009-07-20 2011-01-27 Bracco Spa Therapeutic use of probiotics
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
KR102216603B1 (ko) 2010-08-04 2021-02-17 크레스토보 홀딩스 엘엘씨 분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
SG193348A1 (en) 2011-03-09 2013-10-30 Univ Minnesota Compositions and methods for transplantation of colon microbiota
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
ES2940463T3 (es) * 2012-09-25 2023-05-08 Aquilon Cyl S L Composiciones probióticas y prebióticas
CN114159476A (zh) 2015-05-14 2022-03-11 克雷斯顿沃控股公司 用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
EP3998072A1 (en) 2015-05-22 2022-05-18 Arizona Board of Regents on behalf of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
EP3630190B1 (en) 2017-05-26 2024-02-21 Finch Therapeutics Holdings LLC Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
WO2019032573A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
WO2020069280A1 (en) 2018-09-27 2020-04-02 Crestovo Holdings Llc Compositions and methods for treating epilepsy and related disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
EP0768375B2 (fr) * 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Bactérie lactique

Also Published As

Publication number Publication date
DE760848T1 (de) 1997-08-28
JPH10500577A (ja) 1998-01-20
AU686389B2 (en) 1998-02-05
FI119059B (fi) 2008-07-15
CN1094972C (zh) 2002-11-27
DE69501591D1 (de) 1998-03-12
GR970300016T1 (en) 1997-05-31
HU220190B (hu) 2001-11-28
HUT75555A (en) 1997-05-28
ES2099056T3 (es) 1998-04-01
CA2191213A1 (en) 1995-12-07
NO964966L (no) 1997-01-23
EP0760848B1 (en) 1998-02-04
EP0760848A1 (en) 1997-03-12
HU9603251D0 (en) 1997-01-28
CA2191213C (en) 2008-03-18
FI964681A0 (fi) 1996-11-25
US5709857A (en) 1998-01-20
DE69501591T2 (de) 1998-06-10
ES2099056T1 (es) 1997-05-16
ATE163042T1 (de) 1998-02-15
NZ287420A (en) 1997-12-19
DK0760848T3 (da) 1998-09-23
AU2613995A (en) 1995-12-21
FI964681A (fi) 1997-01-08
BR9507752A (pt) 1997-10-07
MX9605807A (es) 1997-12-31
NO316644B1 (no) 2004-03-22
NO964966D0 (no) 1996-11-22
CN1154715A (zh) 1997-07-16
JP3653277B2 (ja) 2005-05-25
WO1995033046A1 (en) 1995-12-07

Similar Documents

Publication Publication Date Title
HUT75555A (en) Lactobacillus strains of human origin, their compositions and uses thereof
YU15299A (sh) Farmaceutski sastavi
EP0973540A4 (en) INSULATION AND STRUCTURAL ENLARGEMENT OF THE CRYOSTATIC LINEAR AND CYCLO DEPSIPEPTIDE DOLASTATIN 16, DOLASTATIN 17, AND DOLASTATIN 18
DE69905170D1 (en) Thiazolopyrimidinderivate
AP9801392A0 (en) Concentrated antibody preparation.
EP0960107A4 (el)
ZA9710098B (en) Halogenopyrimidines.
BG102781A (en) Isolated dimer fibroblastactivation protein alpha and its application
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
HK1024177A1 (en) Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
MX9602445A (es) Pigmentos dorados.
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
MY112148A (en) Suspension concentrate compositions of arylpyrrole insecticidal and acarricidal agents
BG102667A (en) Diosgenine-containing composition
BG100248A (en) Squalene synthetase inhibitors
MD970269A (en) Clavulanates
AU6849198A (en) Neurotrypsin
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GR850831B (el)
ZA932225B (en) Microorganisms and their isolation and use
MD980129A (en) Antiherpetic remedy
NZ326769A (en) High-content famciclovir tablets
AU6877587A (en) Expellants of phytopathogenic microbes
BG104373A (en) Polymorphous forms of dofetilide